
Pharmacally
ANCA-Associated Vasculitis
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in ANCA-Associated Vasculitis
Health TidingsEMA Panel Recommends Revoking EU Approval of TAVNEOS; CSL Reaffirms Commitment to ANCA-Associated Vasculitis CommunityCSL EMA’s CHMP recommends revoking EU approval of TAVNEOS (avacopan) over Phase 3 ADVOCATE trial data handling concerns. CSL pledges…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.